Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-16-008758
Filing Date
2016-04-08
Accepted
2016-04-08 16:45:05
Documents
53
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1058263
2 ex3-11.htm EX-3.11 57831
3 ex4-11.htm EX-4.11 390739
4 ex4-12.htm EX-4.12 114208
5 ex31-1.htm EX-31.1 19185
6 ex32-1.htm EX-32.1 8769
  Complete submission text file 0001493152-16-008758.txt   3782758

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE sgth-20151231.xml EX-101.INS 351462
8 XBRL SCHEMA FILE sgth-20151231.xsd EX-101.SCH 39593
9 XBRL CALCULATION FILE sgth-20151231_cal.xml EX-101.CAL 30852
10 XBRL DEFINITION FILE sgth-20151231_def.xml EX-101.DEF 136120
11 XBRL LABEL FILE sgth-20151231_lab.xml EX-101.LAB 275780
12 XBRL PRESENTATION FILE sgth-20151231_pre.xml EX-101.PRE 194456
Mailing Address 3477 CORPORATE PARKWAY, SUITE 100 CENTER VALLEY PA 18034
Business Address 3477 CORPORATE PARKWAY, SUITE 100 CENTER VALLEY PA 18034 215-538-9996
SignPath Pharma, Inc. (Filer) CIK: 0001455694 (see all company filings)

EIN.: 205079533 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-158474 | Film No.: 161563141
SIC: 2834 Pharmaceutical Preparations